Science & Research
Telomir Pharmaceuticals Reports Preclinical Breakthrough in Age-Reversal with Telomir-1
Telomir Pharmaceuticals' preclinical results for Telomir-1 show promising age-reversal effects in a zebrafish model of Werner Syndrome, highlighting potential advancements in longevity science.
Annovis Bio Inc. to Host Webcast on Alzheimer’s and Parkinson’s Programs Updates
Annovis Bio Inc. (NYSE: ANVS) is set to host a webcast featuring CEO Maria Maccecchini, Ph.D., to discuss updates on its Phase 3 trial for early Alzheimer’s disease and FDA feedback on its Parkinson’s disease program, highlighting the company's progress in neurodegenerative disease treatments.
Vaughn J. Crichlow Appointed Dean of School of Justice Studies at Roger Williams University
Dr. Vaughn J. Crichlow, a seasoned educator and researcher with over two decades of experience in criminal justice, has been named the new dean of the School of Justice Studies at Roger Williams University, signaling a strong commitment to advancing justice education and research.
New Therapeutic Target Offers Hope in Preventing Cancer from Chronic Gut Inflammation
Research highlights a promising therapeutic target that could prevent cancer in patients suffering from chronic inflammatory bowel diseases like Crohn’s disease and ulcerative colitis, offering new hope for young patients particularly affected by these conditions.
Tonix Pharmaceuticals to Showcase Rheumatologic Research at EULAR 2025
Tonix Pharmaceuticals Holding Corp. is set to present its latest research at the Annual European Congress of Rheumatology (EULAR) 2025, highlighting advancements in rheumatologic conditions and its broader pipeline.
Triad RF Systems Unveils TA1165 Amplifier for Enhanced CubeSat Communications
Triad RF Systems introduces the TA1165 solid-state power amplifier, designed to improve X-Band downlink capabilities for CubeSat and SmallSat missions, marking a significant advancement in satellite communication technology.
Cure Alzheimer’s Fund Strengthens Leadership with New Board Appointments
Cure Alzheimer’s Fund enhances its leadership team by appointing Christine Villas-Boas and Brittany Bowlen to its Board of Directors, aiming to accelerate research against Alzheimer’s disease.
Kairos Pharma Ltd. Showcases Promising Preclinical Results for KROS101 at ASCO 2025
Kairos Pharma Ltd. reveals preclinical data at ASCO 2025 indicating KROS101's potential to enhance cancer immunotherapy by improving T cell activity and reducing immune suppression.
Study Highlights Delayed Cancer Diagnosis in Younger Populations
Research from the University of Nottingham shows younger individuals with certain cancers face longer diagnosis times, underscoring the need for improved detection and treatment strategies.
ProtoSpace Mfg Partners with IREC 2025 to Foster Aerospace Innovation
ProtoSpace Mfg's sponsorship and participation in the International Rocket Engineering Competition (IREC) 2025 highlights its commitment to advancing aerospace education and innovation, offering students unparalleled opportunities to showcase their engineering skills.
Bio-Path Holdings Advances in RNAi Therapeutics with Promising Clinical Trials
Bio-Path Holdings, Inc. makes strides in RNA interference therapeutics, with its DNAbilize® platform showing potential in treating cancers, obesity, and type 2 diabetes, marking a significant step forward in biotechnology.
NanoViricides Advances Measles Drug Program as Global Outbreaks Rise
NanoViricides, Inc. has begun animal trials for its antiviral candidate NV-387, targeting measles amidst increasing global outbreaks and vaccine challenges, highlighting a critical step towards addressing a significant public health gap.
Understanding Pediatric Growth Hormone Deficiency: Impacts and Advances in Treatment
Pediatric Growth Hormone Deficiency (PGHD) affects 1 in 4,000-10,000 children, influencing their growth, development, and overall health, with early diagnosis and treatment offering a path to improved outcomes.
Soligenix Inc. (SNGX) Reports Promising HyBryte Results for CTCL Treatment
Interim data from a Soligenix Inc. study highlights HyBryte's potential as a safer, faster-acting treatment for cutaneous T-cell lymphoma, offering new hope for patients with this chronic condition.
GeoVax to Present COVID-19 Vaccine Breakthroughs at Keystone Symposia
GeoVax Labs, Inc. will showcase data from two key studies at the Keystone Symposia, highlighting the cross-reactivity and broad-spectrum immunity of its COVID-19 vaccine candidates, marking a significant step forward in the fight against evolving SARS-CoV-2 variants.
Scientific American Names David M. Ewalt as New Editor-in-Chief
David M. Ewalt, a seasoned journalist with a strong background in science and technology reporting, has been appointed as the new Editor-in-Chief of Scientific American, signaling a renewed focus on data-driven journalism and the magazine's legacy of scientific exploration.
Q.ANT Unveils Groundbreaking Photonic Computing Technology at ISC 2025
Q.ANT introduces its photonic Native Processing Server at ISC 2025, showcasing significant advancements in energy efficiency and computational performance for AI and scientific workloads.
Dr. Ana Mafé García Unveils the Holy Grail's Journey Through Technology and History
Dr. Ana Mafé García, a leading expert on the Holy Grail, collaborates on an innovative project blending historical research with cutting-edge technology to create an immersive experience of the Grail's journey, highlighting its cultural and educational significance.
Beverly DeVore-Wedding Elected President of National Science Teaching Association
Beverly R. DeVore-Wedding, Ph.D., a seasoned educator and advocate for inclusive science education, has been named the 2025–2026 President of the National Science Teaching Association, marking a significant milestone for science education globally.
Lorati Unveils NanoClay Paste: A Natural Revolution in Wound Care
Lorati Company Limited introduces NanoClay Paste, a natural, mineral-based treatment offering fast and effective healing for chronic wounds and skin infections, marking a significant advancement in non-invasive medical solutions.
D-Wave Quantum Inc. Launches Advantage2 Quantum System, Marking a Significant Leap in Quantum Computing
D-Wave Quantum Inc. has announced the commercial availability of its Advantage2 quantum computing system, featuring over 4,400 qubits and significant improvements in performance, targeting real-world applications in optimization, materials simulation, and AI.
U.S. Naval Sea Cadets Graduate 473, Shaping Future Leaders Across Industries
The U.S. Naval Sea Cadet Corps celebrates the graduation of 473 cadets, showcasing the program's role in developing leadership and resilience among young Americans for careers in military, science, engineering, and beyond.
Telomir Pharmaceuticals Advances Telomere-Targeting Drug, Seeks Strategic Partnerships
Telomir Pharmaceuticals is preparing to submit an Investigational New Drug (IND) application for Telomir-1, a potential breakthrough small molecule targeting aging mechanisms, with plans to explore strategic collaborations at the BIO International Convention 2025.
ESGold Advances Montauban Gold-Silver Project with Innovative Concentration Tests
ESGold Corp. is conducting final spiral concentration tests at its Montauban project, potentially revolutionizing gold and silver extraction by reducing cyanide use and accelerating production timelines.
Molecular 'Velcro' Breakthrough Promises Advanced Drug Delivery and Biosensing Technologies
Researchers introduce a novel supramolecular chemistry concept called controllable ultrahigh-affinity molecular recognition (CUAMR), which offers unprecedented control in molecular interactions with potential transformative applications in biotechnology and medicine.
Global Water Ecological Assessments: A Critical Strategy for Environmental Management
A new study explores the complexity and importance of water ecological assessments worldwide, highlighting their crucial role in ecosystem management, environmental protection, and sustainable resource utilization across different countries and regions.
Researchers Uncover Surprising Flexibility in Key Metabolic Enzyme Complex
A groundbreaking study reveals the dynamic structure of the pyruvate dehydrogenase complex, showing unprecedented flexibility that challenges previous understanding of cellular energy production. The research provides critical insights into metabolic processes with potential implications for disease treatment.
Neuroscientists Develop RADICAL: A Breakthrough Tool for Precise Neural Control
Researchers have engineered a novel chemogenetic tool called RADICAL that enables non-invasive, precise manipulation of brain activity using a synthetic chemical, offering significant potential for neuroscience research and therapeutic interventions.
Swedish Study Reveals Potential Neurological Connection Between Autism and Parkinson's Disease
A groundbreaking research from Karolinska Institutet suggests a significant biological link between autism spectrum disorder and Parkinson's disease, potentially opening new avenues for understanding neurodegenerative conditions.
Lantern Pharma Shows Promise in Pediatric Brain Cancer Treatment
Lantern Pharma's experimental drug LP-184 demonstrates significant potential in treating atypical teratoid rhabdoid tumors (ATRT), a rare and aggressive pediatric brain cancer, with preclinical studies showing remarkable improvements in survival rates.